Liminatus Pharma Inc. (LIMN) Stock Price

0.1824 ▲ +0.0024 (+1.33%)
Open: 0.1797 Vol: 0 Day's range: 0.1797 - 0.1824 May 18, 15:35 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
LIMN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.18▲ 0.18▲ 0.18▲ 0.18▼ 0.19▼
MA10 0.18▼ 0.18▼ 0.18▼ 0.19▼ 0.19▼
MA20 0.18▼ 0.19▼ 0.19▼ 0.20▼ 0.40▼
MA50 0.19▼ 0.19▼ 0.20▼ 0.20▼ 2.37▼
MA100 0.19▼ 0.20▼ 0.20▼ 0.43▼ N/A    
MA200 0.20▼ 0.20▼ 0.20▼ 1.17▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ 0.000▲ 0.000▲ 0.000▼ 0.227▲
RSI 39.579▼ 36.275▼ 35.688▼ 38.872▼ 41.919▼
STOCH 12.591▼ 12.046▼ 12.046▼ 11.577▼ 35.103    
WILL %R -73.267     -73.267     -73.267     -88.750▼ -81.215▼
CCI -33.586     -28.291     -27.759     -126.257▼ -99.526    
Latest Filters Detected On LIMN
▼ MACD $LIMN MACD(12,26,9) Crossed Below Signal Line Set Alert
▼ GAP $LIMN Open Gap Down %2 Set Alert
▼ BREAK $LIMN Price Breaks 20 Days Low Set Alert
▼ BREAK $LIMN Price Breaks 10 Days Low Set Alert
CDL $LIMN Doji Candlestick Pattern Detected Set Alert
Liminatus Pharma Inc. News
Liminatus Pharma, Inc. Class A Common Stock (LIMN) Pre-Market Quote
Tuesday, April 07, 2026 05:17 PM
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Thursday, October 30, 2025 08:04 AM
LA PALMA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (LIMN), a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it ...
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Tuesday, October 28, 2025 07:42 AM
La Palma, CA October 27, 2025 –(PR.com)– Liminatus Pharma, Inc. (NASDAQ: LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced ...
LIMN historical stock data
date open high low close volume
18/05/26 0.1797 0.1824 0.1797 0.1824 1,142,943
15/05/26 0.18 0.189 0.177 0.18 753,118
14/05/26 0.1871 0.19 0.181 0.184 498,787
13/05/26 0.1897 0.1937 0.185 0.185 595,847
12/05/26 0.1988 0.2044 0.186 0.1915 683,306
11/05/26 0.2005 0.206 0.20 0.205 571,769
08/05/26 0.2047 0.2059 0.1983 0.2028 700,319
07/05/26 0.2009 0.208 0.2005 0.2005 447,666
06/05/26 0.2036 0.21 0.2036 0.205 662,240
05/05/26 0.225 0.225 0.208 0.208 346,623
Quote Details
52wk Low:0.159
52wk High:33.66
Vol:0
Avg Vol(3m):62.4M
1Y Chng:-98.56%
1M Chng:-1.14%
Add to Watch List
More Information
Index US Composite
Market Cap. 8.26M